The B.1.617 variant is one of the reasons India is currently battling the world's worst surge in Covid-19. Jameel had also told Reuters that authorities were...
The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield are currently being used in India's inoculation drive against coronavirus.